Literature DB >> 20620555

Torsades de pointes triggered by severe diastolic hypotension with low hematocrit in the neohepatic stage of liver transplantation: a case report.

J H Chin1, J Y Park, Y K Kim, S H Kim, Y G Kong, P H Park, G S Hwang.   

Abstract

We have described herein a 39-year-old male patient with hepatitis B virus-related cirrhosis (Child class C), showing a prolonged corrected QT interval, who developed torsades de pointes (TdP) in the neohepatic stage of liver transplantation (LT). There was no arrhythmia in the pre-anhepatic and anhepatic stages. Multiple premature ventricular complexes, ventricular tachycardia, and TdP suddenly developed at 16 minutes after graft reperfusion without any prodromal arrhythmia; they persisted for 118 seconds. Laboratory tests showed that serum potassium, calcium, and magnesium concentrations of 4.7 mmol/L, 1.05 mmol/L, and 1.85 mg/dL, respectively were within normal ranges. Likely causative factors for TdP in this patient included a prolonged corrected QT interval (553 msec), a low hematocrit (21%), and a low arterial blood pressure (systolic blood pressure, 80-90 mm Hg; diastolic blood pressure; 20-26 mm Hg) in the neohepatic stage. This case demonstrated the importance of optimal maintenance of coronary perfusion, with an adequate hematocrit level and electrolyte concentrations, to prevent the development of TdP in cirrhotic patients with a prolonged corrected QT interval during LT.

Entities:  

Mesh:

Year:  2010        PMID: 20620555     DOI: 10.1016/j.transproceed.2010.02.093

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

Review 1.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

Review 2.  Perioperative torsade de pointes: a systematic review of published case reports.

Authors:  Joshua Johnston; Swatilika Pal; Peter Nagele
Journal:  Anesth Analg       Date:  2013-06-06       Impact factor: 5.108

3.  [Perioperative treatment of patients with long QT syndrome].

Authors:  T Krönauer; P Friederich
Journal:  Anaesthesist       Date:  2015-08       Impact factor: 1.041

4.  Prevalent metabolic derangement and severe thrombocytopenia in ABO-incompatible liver recipients with pre-transplant plasma exchange.

Authors:  Hye-Mee Kwon; In-Gu Jun; JungBok Lee; Young-Jin Moon; Kyeo-Woon Jung; Hye-Won Jeong; Yong-Seok Park; Jun-Gol Song; Gyu-Sam Hwang
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

5.  Propofol prevents further prolongation of QT interval during liver transplantation.

Authors:  Seung Hyun Kim; Jae Geun Lee; Hyang Mi Ju; SuYoun Choi; Hyukjin Yang; Bon-Nyeo Koo
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

6.  Predicting Short-term Survival after Liver Transplantation using Machine Learning.

Authors:  Chien-Liang Liu; Ruey-Shyang Soong; Wei-Chen Lee; Guo-Wei Jiang; Yun-Chun Lin
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.